Article
Antisense Oligonucleotide Therapy for Calmodulinopathy
19 Aug 2024
Abstract excerpt
BACKGROUND: Calmodulinopathies are rare inherited arrhythmia syndromes caused by dominant heterozygous variants in CALM1 , CALM2 , or CALM3 , which each encode the identical CaM (calmodulin) protein. We hypothesized that antisense oligonucleotide (ASO)–mediated depletion of an affected calmodulin gene would ameliorate disease manifestations, whereas the other 2 calmodulin genes would preserve CaM level and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
